Clinical Efficacy of Fuzheng Guben Anticancer Decoction Combined with Taxol in Treating Ovarian Carcinoma and Its Effect on Complication Incidence

Table 3

Between-group comparison of levels of tumor markers ( ± s).

Test indicator		Control	Experimental	t/P
CA125 (U/ml)	Before treatment	90.86 ± 14.55	90.57 ± 14.33
	After treatment	55.83 ± 10.62	33.02 ± 10.13	9.829/<0.001
CA199 (IU/L)	Before treatment	50.86 ± 6.64	51.02 ± 6.71
	After treatment	30.91 ± 4.17	21.75 ± 4.39	9.568/<0.001
CEA (ng/ml)	Before treatment	27.25 ± 4.88	27.17 ± 4.79
	After treatment	20.35 ± 3.22	16.02 ± 3.07	6.155/<0.001

indicated in the comparison of patients in the same group before and after treatment.